Cargando…

Age-period-cohort analysis of lung cancer mortality in China and Australia from 1990 to 2019

Lung cancer (LC) is the leading cause of cancer death in China and Australia, the countries with different socioenvironmental contexts in the Western Pacific Region. Comparing the age-period-cohort effect on LC mortality (LCM) between the two countries can help plan interventions and draw lessons fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ning, Xu, Zhiwei, Lui, Chi-Wai, Wang, Baohua, Hu, Wenbiao, Wu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120450/
https://www.ncbi.nlm.nih.gov/pubmed/35589955
http://dx.doi.org/10.1038/s41598-022-12483-z
_version_ 1784710927862464512
author Wang, Ning
Xu, Zhiwei
Lui, Chi-Wai
Wang, Baohua
Hu, Wenbiao
Wu, Jing
author_facet Wang, Ning
Xu, Zhiwei
Lui, Chi-Wai
Wang, Baohua
Hu, Wenbiao
Wu, Jing
author_sort Wang, Ning
collection PubMed
description Lung cancer (LC) is the leading cause of cancer death in China and Australia, the countries with different socioenvironmental contexts in the Western Pacific Region. Comparing the age-period-cohort effect on LC mortality (LCM) between the two countries can help plan interventions and draw lessons for countries in the region. We collected LCM estimates between 1990 and 2019 from the GBD 2019. Age-period-cohort modelling was applied to compute the net drift, local drift, cross-sectional age curve, longitudinal age curve, and the rate ratios (RRs) of period and cohort. China had a higher LC age-standardized mortality rate than Australia in 2019 (men: 58.10 [95% uncertainty interval (UI): 46.53, 70.89] vs. 30.13 [95% UI: 27.88, 32.31]/100,000 population; women: 22.86 [95% UI: 18.52, 27.52] vs. 17.80 [95% UI: 15.93, 19.34]/100,000 population). Period and cohort effects on LCM improved more markedly among Australian men (RR for period effect, from 1.47 [95% confidence interval (CI) 1.41, 1.53] to 0.79 [95% CI 0.75, 0.84]; RR for cohort effect, from 2.56 [95% CI 2.44, 2.68] to 0.36 [95% CI 0.11, 1.18]) and Chinese women (RR for period effect, from 1.06 [95% CI 1.01, 1.11] to 0.85 [95% CI 0.82, 0.89]; RR for cohort effect, from 0.71 [95% CI 0.65, 0.78] to 0.51 [95% CI 0.26, 1.03]) during the study period and birth cohort. The LCM in Chinese population aged 65 to 79 and Australian women aged 75 to 79 increased. Smoking and particulate matter (PM) contributed most to LCM in China, while smoking and occupational carcinogens contributed most in Australia. Decreasing period and cohort risks for LCM attributable to smoking and PM were more remarkable in Australia than in China. The LCM attributable to occupational carcinogens was higher in Australia than in China, particularly for those aged 60 to 79. Vigorous tobacco and PM control, which brought a substantial decline in LCM in Australia, may help reduce LCM in China. Australia should highlight LC prevention among people with occupational exposure. Chinese aged ≥ 65 and Australian women aged ≥ 75 should be the priorities for LC interventions.
format Online
Article
Text
id pubmed-9120450
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-91204502022-05-21 Age-period-cohort analysis of lung cancer mortality in China and Australia from 1990 to 2019 Wang, Ning Xu, Zhiwei Lui, Chi-Wai Wang, Baohua Hu, Wenbiao Wu, Jing Sci Rep Article Lung cancer (LC) is the leading cause of cancer death in China and Australia, the countries with different socioenvironmental contexts in the Western Pacific Region. Comparing the age-period-cohort effect on LC mortality (LCM) between the two countries can help plan interventions and draw lessons for countries in the region. We collected LCM estimates between 1990 and 2019 from the GBD 2019. Age-period-cohort modelling was applied to compute the net drift, local drift, cross-sectional age curve, longitudinal age curve, and the rate ratios (RRs) of period and cohort. China had a higher LC age-standardized mortality rate than Australia in 2019 (men: 58.10 [95% uncertainty interval (UI): 46.53, 70.89] vs. 30.13 [95% UI: 27.88, 32.31]/100,000 population; women: 22.86 [95% UI: 18.52, 27.52] vs. 17.80 [95% UI: 15.93, 19.34]/100,000 population). Period and cohort effects on LCM improved more markedly among Australian men (RR for period effect, from 1.47 [95% confidence interval (CI) 1.41, 1.53] to 0.79 [95% CI 0.75, 0.84]; RR for cohort effect, from 2.56 [95% CI 2.44, 2.68] to 0.36 [95% CI 0.11, 1.18]) and Chinese women (RR for period effect, from 1.06 [95% CI 1.01, 1.11] to 0.85 [95% CI 0.82, 0.89]; RR for cohort effect, from 0.71 [95% CI 0.65, 0.78] to 0.51 [95% CI 0.26, 1.03]) during the study period and birth cohort. The LCM in Chinese population aged 65 to 79 and Australian women aged 75 to 79 increased. Smoking and particulate matter (PM) contributed most to LCM in China, while smoking and occupational carcinogens contributed most in Australia. Decreasing period and cohort risks for LCM attributable to smoking and PM were more remarkable in Australia than in China. The LCM attributable to occupational carcinogens was higher in Australia than in China, particularly for those aged 60 to 79. Vigorous tobacco and PM control, which brought a substantial decline in LCM in Australia, may help reduce LCM in China. Australia should highlight LC prevention among people with occupational exposure. Chinese aged ≥ 65 and Australian women aged ≥ 75 should be the priorities for LC interventions. Nature Publishing Group UK 2022-05-19 /pmc/articles/PMC9120450/ /pubmed/35589955 http://dx.doi.org/10.1038/s41598-022-12483-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Wang, Ning
Xu, Zhiwei
Lui, Chi-Wai
Wang, Baohua
Hu, Wenbiao
Wu, Jing
Age-period-cohort analysis of lung cancer mortality in China and Australia from 1990 to 2019
title Age-period-cohort analysis of lung cancer mortality in China and Australia from 1990 to 2019
title_full Age-period-cohort analysis of lung cancer mortality in China and Australia from 1990 to 2019
title_fullStr Age-period-cohort analysis of lung cancer mortality in China and Australia from 1990 to 2019
title_full_unstemmed Age-period-cohort analysis of lung cancer mortality in China and Australia from 1990 to 2019
title_short Age-period-cohort analysis of lung cancer mortality in China and Australia from 1990 to 2019
title_sort age-period-cohort analysis of lung cancer mortality in china and australia from 1990 to 2019
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120450/
https://www.ncbi.nlm.nih.gov/pubmed/35589955
http://dx.doi.org/10.1038/s41598-022-12483-z
work_keys_str_mv AT wangning ageperiodcohortanalysisoflungcancermortalityinchinaandaustraliafrom1990to2019
AT xuzhiwei ageperiodcohortanalysisoflungcancermortalityinchinaandaustraliafrom1990to2019
AT luichiwai ageperiodcohortanalysisoflungcancermortalityinchinaandaustraliafrom1990to2019
AT wangbaohua ageperiodcohortanalysisoflungcancermortalityinchinaandaustraliafrom1990to2019
AT huwenbiao ageperiodcohortanalysisoflungcancermortalityinchinaandaustraliafrom1990to2019
AT wujing ageperiodcohortanalysisoflungcancermortalityinchinaandaustraliafrom1990to2019